Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LUPKYNIS™ safely and effectively. See full prescribing information for LUPKYNIS. LUPKYNIS (voclosporin) capsules, for oral use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
LUPKYNIS is indicated in combination with a background immunosuppressive therapy regimen [see Clinical Studies( 14)] for the treatment of adult patients with active lupus nephritis (LN). Limitations of Use: Safety and efficacy of LUPKYNIS have not been established in combination with cyclophosphamide. Use of LUPKYNIS is not recommended in this situation.
- generic_name
- voclosporin
- product_names
- Voclosporin
- ndc
- 75626-001, 75626-001-01, 75626-001-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en